We are currently recruiting patients for clinical trials of our AAV gene therapy programs. You can learn more about the clinical trial participation process and how to participate.
What is a clinical trial?
Clinical trials are a key step in the new drug research process, and are mainly used to verify the safety, tolerability, and effectiveness of new drug products in the human body.
New drug review agencies need to rely on clinical trial data and other relevant information to determine whether the clinical trial drug should be approved for use on a larger scale.
Why participate in a clinical trial?
Clinical trials are a critical step in verifying the safety and effectiveness of new drugs and therapies. By participating in trials, individuals can help scientists and doctors better understand and improve treatments for diseases. The data of each participant helps accumulate medical knowledge, helps future research find effective treatments more quickly, and is critical to future patients.
For participating subjects, participating in clinical trials can provide access to the latest, not yet widely used treatments that may be more effective than existing treatments. Participants typically receive more detailed monitoring and follow-up than conventional medical care, which helps to better manage and understand their health status.
The process of participating in a clinical trial
Each clinical trial needs to follow a trial protocol, which clearly specifies the process of conducting the trial and specific patient inclusion and exclusion criteria, such as age, gender, disease characteristics and other criteria. Before participating in a clinical trial, you need to contact the doctor or researcher at the research center to determine whether the clinical trial is suitable for you or your relatives. After successfully applying, the researcher will assist you or your relatives in the screening process to finally determine whether you can participate in the clinical trial. Each clinical trial will clearly define the inclusion and exclusion criteria. Subjects must meet the inclusion criteria to participate in the clinical trial, so not every patient who applies to participate can be successfully enrolled. Before officially participating in a clinical trial, you should also go through the informed consent process. During the informed consent communication process, the research doctor will explain the potential risks of participating in the clinical trial and other important information to the subjects and/or relatives to ensure that the subjects and relatives can fully understand the risk information and make a more informed decision on whether to participate in the clinical trial. During the clinical trial, the subjects may need to return to the research center regularly for follow-up. In gene therapy clinical trials, in order to better observe the long-term treatment effect and the growth and development of the subjects, the follow-up time may be as long as several years. Therefore, if possible, please try to choose a research center that is close to home or has convenient transportation to and from home.
What do you need to know before participating in a clinical trial
Deciding whether to participate in a clinical trial can be a mixture of hope and nervousness. Although every clinical trial is different, they all have some common features: 1. During the informed consent phase, researchers will tell you about the risks, potential benefits, and other information about the study. This information will help you make a more informed decision. 2. The duration of a clinical trial depends on the study. Some studies may be very short, while others may have a long-term follow-up program. 3. Participants may need to travel long distances to an out-of-town center to participate in the trial and may undergo more tests than those who do not participate in the trial. 4. Participants may be asked to keep a record of their health conditions, fill out forms, or provide other forms of reports. 5. After confirming participation in the clinical trial, participants will need to sign an informed consent form to indicate that they are fully informed. However, this is not binding, and participants can withdraw from the trial at any time. The treatment drugs in the clinical trial phase may be effective or ineffective. In some clinical trials, a control group is set up, and the subjects who are randomly assigned to the control group will receive a placebo treatment at a specific stage or throughout the trial. Even if the clinical trial does not ultimately enhance or improve the condition of the subjects, or the research drug is not ultimately approved, all subjects who participated in the clinical trial have given more value and significance to the medical diagnosis and treatment of rare diseases.
Recruitment and screening are carried out by research doctors and department researchers at the research center.We only provide you with liaison access to the clinical research team.
